Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fairooz F. Kabbinavar, MD
Jonsson Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
Recruiting - Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
Recruiting - Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Recruiting - Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Recruiting - Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Recruiting - Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Recruiting - Our Lady of Mercy Medical Center Comprehensive Cancer Center
The Bronx, New York, United States
Recruiting - Providence Cancer Center at Providence Portland Medical Center
Portland, Oregon, United States
Recruiting - Upmc Cancer Centers
Pittsburgh, Pennsylvania, United States
Recruiting - Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Recruiting - University of Virginia Cancer Center
Charlottesville, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- —
- Completion
- —
- Last update posted
- 10 Jan 2014
- Registered enrollment
- 65
- Registry id
- NCT00301990
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.